|
11
|
114
|
1bljA |
Nmr ensemble of blk sh2 domain, 20 structures |
|
5
|
67
|
1awwA |
Sh3 domain from bruton's tyrosine kinase, nmr, 42 structures |
|
1
|
44
|
1cf4B |
Cdc42/ack gtpase-binding domain complex |
|
53
|
139
|
1ktmA |
Solution structure of fat domain of focal adhesion kinase |
|
4
|
57
|
1awoA |
The solution nmr structure of abl sh3 and its relationship to sh2 in the sh(32) construct, 20 structures |
|
14
|
107
|
1hctB |
Nmr structure of the human src sh2 domain complex |
|
10
|
51
|
1f62A |
Wstf-phd |
|
14
|
114
|
1blkA |
Nmr ensemble of blk sh2 domain using chemical shift refinement, 20 structures |
|
7
|
63
|
1h92A |
Sh3 domain of human lck tyrosine kinase |
|
11
|
106
|
1aouF |
Nmr structure of the fyn sh2 domain complexed with a phosphotyrosyl peptide, 22 structures |
|
8
|
57
|
1kikA |
Sh3 domain of lymphocyte specific kinase (lck) |
|
11
|
67
|
1gl5A |
Nmr structure of the sh3 domain from the tec protein tyrosine kinase |
|
13
|
109
|
1ab2A |
Three-dimensional solution structure of the src homology 2 domain of c-abl |
|
11
|
112
|
1csyA |
Syk tyrosine kinase c-terminal sh2 domain complexed with a phosphopeptidefrom the gamma chain of the high affinity immunoglobin g receptor, nmr |
|
74
|
289
|
6d3kA |
Crystal structure of unphosphorylated human pkr kinase domain in complex with adp |
|
66
|
284
|
6d3lA |
Crystal structure of unphosphorylated human pkr |
|
0
|
8
|
6ehjD |
Human n-myristoyltransferase (nmt1) with myristoyl-coa and peptide bound |
|
12
|
58
|
2o88A |
Crystal structure of the n114a mutant of abl-sh3 domain complexed with a designed high-affinity peptide ligand: implications for sh3-ligand interactions |
|
0
|
9
|
1fbvB |
Structure of a cbl-ubch7 complex: ring domain function in ubiquitin-protein ligases |
|
0
|
9
|
3zniB |
Structure of phosphotyr363-cbl-b - ubch5b-ub - zap-70 peptide complex |
|
0
|
9
|
3buwA |
Crystal structure of c-cbl-tkb domain complexed with its binding motif in syk |
|
12
|
63
|
6ipzZ |
Fyn sh3 domain r96w mutant, crystallized with 18-crown-6 |
|
89
|
271
|
6hm7A |
Crystal structure of spleen tyrosine kinase (syk) in complex with a 2-(phenoxymethyl)pyridine inhibitor |
|
11
|
67
|
6ipyA |
His-tagged fyn sh3 domain r96i mutant |
|
86
|
269
|
6hm6A |
Crystal structure of spleen tyrosine kinase (syk) in complex with a 2-(pyridinyloxymethyl)pyridine inhibitor |
|
89
|
306
|
6hmxA |
Rip2 kinase catalytic domain complex with n(4,5dimethyl1hpyrazol3yl)7methoxy6(2methylpropane2sulfonyl)quinolin4amine |
|
90
|
288
|
6hd4A |
Abl1 in complex with compound 7 and imatinib (sti-571) |
|
86
|
287
|
6dudA |
Jak3 with cyanamide cp12 |
|
18
|
86
|
6ggsA |
Structure of rip2 card filament |
|
87
|
287
|
6db4A |
Jak3 with cyanamide cp34 |
|
90
|
301
|
6elrA |
Human jak1 kinase domain in complex with compound 7 |
|
91
|
271
|
6di1A |
Crystal structure of btk in complex with covalent fragment ligand |
|
84
|
287
|
6db3A |
Jak3 with cyanamide cp23 |
|
92
|
271
|
6di0A |
Crystal structure of btk in complex with fragment ligand |
|
84
|
285
|
6da4A |
Jak3 with cyanamide cp10 |
|
87
|
264
|
6blnA |
Btk complex with compound 13 |
|
88
|
266
|
6bkwA |
Btk complex with compound 12 |
|
87
|
263
|
6bkhA |
Btk complex with compound 11 |
|
86
|
264
|
6bikA |
Btk complex with compound 7 |
|
82
|
264
|
6bkeA |
Btk complex with compound 10 |
|
86
|
269
|
6npuA |
C-abl kinase domain with the activator(cmpd29), n-(1-(3,4-dichlorophenyl)-4,5-dihydro-1h-pyrazol-3-yl)acetamide |
|
88
|
269
|
6npeA |
C-abl kinase domain with the activator(cmpd6), 2-cyano-n-(4-(3,4-dichlorophenyl)thiazol-2-yl)acetamide |
|
88
|
269
|
6npvA |
C-abl kinase domain with the activator(cmpd51), n-(1-(3,4-dichlorophenyl)-4-(2-hydroxyethyl)-4,5-dihydro-1h-pyrazol-3-yl)isonicotinamide |
|
26
|
87
|
5yrnA |
Structure of rip2 card domain |
|
89
|
271
|
6n9pA |
Discovery of affinity-based probes for btk occupancy assay |
|
79
|
268
|
6nfiA |
Btk in complex with inhibitor n-(3-{[(2,6-dimethylphenyl)methyl]amino}-7-methoxyindeno[1,2-c]pyrazol-6-yl)methanesulfonamide |
|
90
|
271
|
6nfhA |
Btk in complex with inhibitor 8-(2,3-dihydro-1h-inden-5-yl)-2-({4-[(2s)-3-(dimethylamino)-2-hydroxypropoxy]phenyl}amino)-5,8-dihydropteridine-6,7-dione |
|
84
|
275
|
6i8zA |
Crystal structure of ptk2 in complex with bi-4464. |
|
77
|
262
|
6mnyA |
Crystal structure of mouse btk kinase domain in complex with compound 9a |
|
13
|
74
|
6c4sA |
Human csrc sh3 domain in complex with choline kinase fragment 60-69 |
